The Latest Breaking News from Vaccine

Stocks nudge higher on strong China data after February slump; Novavax plunges as vaccine maker casts doubt on company's future; HP shares get boost from solid profit outlook, cost-cutting; Lowe's earnings on deck after muted Home Depot spending outlook and Salesforce earnings to highlight extent of activist pressure on CEO…

A report that the COVID-19 virus leaked from a lab in China is the latest former right wing “conspiracy theory” that’s gaining traction and undermining trust in government.

Washington (AFP) - Covid-19 vaccine maker Novavax raised doubts Tuesday about its ability to continue its business, announcing plans to cut spending after struggles in rolling out its coronavirus jab.

Defense officials are telling Congress that the military services are still reviewing possible discipline of troops who refused the order to get the COVID-19 vaccine

Pfizer is also facing off with collaborators Sanofi and AstraZeneca Plc to develop prevention for dangerous RSV infections in newborns, a market that could reach $1.5 billion.

The party compiled a ‘catalogue of waste’ from the PM’s time as Chancellor and Chief Secretary to the Treasury.

Federal health advisers have narrowly backed an experimental vaccine from Pfizer that could become the first shot to protect older adults against the respiratory illness known as RSV

WASHINGTON — Pfizer Inc.’s vaccine for respiratory syncytial virus received endorsement from a key panel of U.S. advisers for its safety in people 60 and older, a key endorsement for the drugmaker’s potential product.

Vaccine status of more than 400 children near Bilbao investigated amid concerns about anti-vaxxer nurse

Vaccines are under attack in Texas, and public health experts warn we'll pay a price in more outbreaks and deaths from preventable diseases.

Victoria has expanded Japanese encephalitis vaccine eligibility to include more local government areas, after data indicated broader infection in the community.